Skip to main content
. 2026 Jul 27;18(15):2414. doi: 10.3390/cancers18152414
AJCC 7 American Joint Committee on Cancer, 7th edition
CanSaRCC Canadian Sarcoma Research and Clinical Collaboration
CI Confidence interval
CNS Central nervous system
CT Chemotherapy
DMFS Distant metastasis-free survival
DRFS Distant recurrence-free survival
DSS Disease-specific survival
FNCLCC Fédération nationale des centres de lutte contre le cancer
G1 Grade 1
G2 Grade 2
G3 Grade 3
Gy Gray
HR Hazard ratio
I2 I-squared statistic for heterogeneity
IQR Interquartile range
LRFS Local recurrence-free survival
MFS Metastasis-free survival
MFH Malignant fibrous histiocytoma
MPNST Malignant peripheral nerve sheath tumor
N/A Not applicable
NOS Newcastle–Ottawa Scale
OS Overall survival
PLD Pegylated liposomal doxorubicin
PRISMA Preferred Reporting Items for Systematic Reviews and Meta-Analyses
PROSPERO International Prospective Register of Systematic Reviews
PRS Post-radiation sarcoma
R0 Microscopically margin-negative resection
R1 Microscopically margin-positive resection
R2 Macroscopically incomplete resection/macroscopic residual disease
RFS Relapse-free survival
RIS Radiation-induced sarcoma
RT Radiotherapy
SD Standard deviation
UPS Undifferentiated pleomorphic sarcoma